(Q34799921)

4 August 2017

title

Final height in central precocious puberty after long term treatment with a slow release GnRH agonist (English)

1 reference

4 August 2017

1 reference

Oostdijk W

1

1 reference

4 August 2017

Rikken B

2

1 reference

4 August 2017

Schreuder S

3

1 reference

4 August 2017

Otten B

4

1 reference

4 August 2017

Odink R

5

1 reference

4 August 2017

Rouwé C

6

1 reference

4 August 2017

Jansen M

7

1 reference

4 August 2017

Gerver WJ

8

1 reference

4 August 2017

Waelkens J

9

1 reference

4 August 2017

Drop S

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Archives of Disease in Childhood

4 August 2017

published in

1 reference

4 August 2017

volume

75

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

292-297

1 reference

Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Precocious puberty. A report of 96 cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

New concepts of the growth spurt of puberty

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Preserving adult height potential in girls with idiopathic true precocious puberty

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Adult height in precocious puberty after long-term treatment with deslorelin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Adult height in girls with idiopathic true precocious puberty

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Ultrasound evaluation of uterine and ovarian size from birth to puberty

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Effects of leuprolide in the treatment of central precocious puberty

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1511728

Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue

26 October 2018

1 reference

12 December 2020

Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy

1 reference

12 December 2020

The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty

1 reference

12 December 2020

Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin)

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.75.4.292

1 reference

4 August 2017

1 reference

4 August 2017

1 reference